Search Results - "Kerns, B. M."

Statistical Characterization and Process Control for Improved Growth of La2−xSrxCuO4 Films by Clayhold, J. A., Pelleg, O., Bollinger, A. T., Logvenov, G., Kerns, B. M., Schroer, M. D., Rench, D. W., Bozovic, I.

“…We have used combinatorial molecular beam epitaxy (COMBE) technique to deposit thin cuprate films with continuous spread in chemical composition, as well as…”
Get full text

Constraints on Models of Electrical Transport in Optimally Doped La2−x Sr x CuO4 from Measurements of Radiation-Induced Defect Resistance by Clayhold, J. A., Pelleg, O., Ingram, D. C., Bollinger, A. T., Logvenov, G., Rench, D. W., Kerns, B. M., Schroer, M. D., Sundling, R. J., Bozovic, I.

Get full text

Statistical Characterization and Process Control for Improved Growth of La2−x Sr x CuO4 Films by Clayhold, J. A., Pelleg, O., Bollinger, A. T., Logvenov, G., Kerns, B. M., Schroer, M. D., Rench, D. W., Bozovic, I.

“…We have used combinatorial molecular beam epitaxy (COMBE) technique to deposit thin cuprate films with continuous spread in chemical composition, as well as…”
Get full text

Constraints on Models of Electrical Transport in Optimally Doped La2−xSrxCuO4 from Measurements of Radiation-Induced Defect Resistance by Clayhold, J. A., Pelleg, O., Ingram, D. C., Bollinger, A. T., Logvenov, G., Rench, D. W., Kerns, B. M., Schroer, M. D., Sundling, R. J., Bozovic, I.

“…Precise measurements of the temperature dependence of additional resistivity caused by defect scattering were used to constrain models of carrier transport in…”
Get full text

The SeaQuest spectrometer at Fermilab by Aidala, C.A., Arrington, J.R., Ayuso, C., Bowen, B.M., Bowen, M.L., Bowling, K.L., Brown, A.W., Brown, C.N., Byrd, R., Carlisle, R.E., Chang, T., Chang, W.-C., Chen, A., Chen, J.-Y., Christian, D.C., Chu, X., Dannowitz, B.P., Daugherity, M., Diefenthaler, M., Dove, J., Durandet, C., El Fassi, L., Erdos, E., Fox, D.M., Geesaman, D.F., Gilman, R., Goto, Y., Guo, L., Guo, R., Hague, T., Hicks, C.R., Holt, R.J., Isenhower, D., Jiang, X., Katich, J.M., Kerns, B.M., Kinney, E.R., Kitts, N.D., Klein, A., Kleinjan, D., Kras, J., Kudo, Y., Lin, P.-J., Liu, D., Liu, K., Liu, M.X., Lorenzon, W., Makins, N.C.R., Martinez, J.D., McClellan, R.E., McDonald, B., McGaughey, P.L., McNease, S.E., Medeiros, M.M., Miller, B., Miller, A.J., Miyasaka, S., Miyachi, Y., Mooney, I.A., Morton, D.H., Nadim, B., Nagai, K., Nakahara, K., Nakano, K., Nara, S., Obata, S., Peng, J.C., Prasad, S., Puckett, A.J.R., Ramson, B.J., Raymond, R.S., Reimer, P.E., Rubin, J.G., Salinas, R., Sanftl, F., Sawada, S., Sawada, T., Scott, M.B.C., Selensky, L.E., Shibata, T.-A., Shiu, S., Su, D., Tadepalli, A.S., Teo, M., Tice, B.G., Towell, C.L., Towell, R.S., Uemura, S., Wang, S.G., Watson, S., White, N., Wickes, A.B., Wood, M.R., Wu, J., Xi, Z., Ye, Z., Yin, Y.

“…The SeaQuest spectrometer at Fermilab was designed to detect oppositely-charged pairs of muons (dimuons) produced by interactions between a 120 GeV proton beam…”
Get full text

Overexpression of p53 and HER-2/ neu proteins as prognostic markers in early stage breast cancer by MARKS, J. R, HUMPHREY, P. A, WU, K, BERRY, D, BANDARENKO, N, KERNS, B.-J. M, IGLEHART, J. D

“…Overexpression of the p53 and HER-2/neu oncogenes are the two most common genetic abnormalities associated with breast cancer. Shorter survival time has been…”
Get full text

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer by Kohler, M F, Kerns, B J, Humphrey, P A, Marks, J R, Bast, Jr, R C, Berchuck, A

“…To investigate whether mutation and overexpression of p53 is a feature of early-stage ovarian cancers. Because early-stage ovarian cancers are relatively…”
Get more information

The SeaQuest Spectrometer at Fermilab by SeaQuest Collaboration, Aidala, C. A, Arrington, J. R, Ayuso, C, Bowen, B. M, Bowen, M. L, Bowling, K. L, Brown, A. W, Brown, C. N, Byrd, R, Carlisle, R. E, Chang, T, Chang, W. -C, Chen, A, Chen, J. -Y, Christian, D. C, Chu, X, Dannowitz, B. P, Daugherity, M, Diefenthaler, M, Dove, J, Durandet, C, Fassi, L. El, Erdos, E, Fox, D. M, Geesaman, D. F, Gilman, R, Goto, Y, Guo, L, Guo, R, Hague, T, Hicks, C. R, Holt, R. J, Isenhower, D, Jiang, X, Katich, J. M, Kerns, B. M, Kinney, E. R, Kitts, N. D, Klein, A, Kleinjan, D, Kras, J, Kudo, Y, Lin, P. -J, Liu, D, Liu, K, Liu, M. X, Lorenzon, W, Makins, N. C. R, Martinez, J. D, McClellan, R. E, McDonald, B, McGaughey, P. L, McNease, S. E, Medeiros, M. M, Miller, B, Miller, A. J, Miyasaka, S, Miyachi, Y, Mooney, I. A, Morton, D. H, Nadim, B, Nagai, K, Nakahara, K, Nakano, K, Nara, S, Obata, S, Peng, J. C, Prasad, S, Puckett, A. J. R, Ramson, B. J, Raymond, R. S, Reimer, P. E, Rubin, J. G, Salinas, R, Sanftl, F, Sawada, S, Sawada, T, Scott, M. B. C, Selensky, L. E, Shibata, T. -A, Shiu, S, Su, D, Tadepalli, A. S, Teo, M, Tice, B. G, Towell, C. L, Towell, R. S, Uemura, S, Wang, S. G, Watson, S, White, N, Wickes, A. B, Wood, M. R, Wu, J, Xi, Z, Ye, Z, Yin, Y

“…The SeaQuest spectrometer at Fermilab was designed to detect oppositely-charged pairs of muons (dimuons) produced by interactions between a 120 GeV proton beam…”
Get full text

Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas by Wiener, Jon R., Hurteau, Jean A., Kerns, Billie-Jo M., Whitaker, Regina S., Conaway, Mark R., Berchuck, Andrew, Bast, Robert C.

“…OBJECTIVE: Our purpose was to determine whether protein tyrosine phosphatase 1B is overexpressed in ovarian cancers, possibly altering the balance of…”
Get full text

Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance by Layfield, Lester J., Saria, Elizabeth A., Conlon, Debbi H., Kerns, Billie-Jo M.

“…The quantitation of estrogen and progesterone receptors (ER and PgR) has become the standard of care in the evaluation of patients with primary breast…”
Get full text

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry by Kerns, BJ, Jordan, PA, Moore, MB, Humphrey, PA, Berchuck, A, Kohler, MF, Bast, RC, Jr, Iglehart, JD, Marks, JR

“…Mutation and overexpression of the p53 gene have been noted in a wide range of human cancers and are thought to play a role in malignant transformation…”
Get full text

Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis by Kerns, B J, Jordan, P A, Faerman, L L, Berchuck, A, Bast, Jr, R C, Layfield, L J

“…A new monoclonal antibody, MIB-1, reacts with the same epitope recognized by Ki-67. The authors investigated the feasibility of using image analysis to…”
Get more information

Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues by Ibrahim, G K, Kerns, B J, MacDonald, J A, Ibrahim, S N, Kinney, R B, Humphrey, P A, Robertson, C N

“…To investigate epidermal growth factor receptor (EGFr) presence in the prostate, monoclonal antibody (clone EGFR1) immunohistochemical examination of radical…”
Get more information

Expression of cell regulatory proteins in ovarian borderline tumors by van Haaften‐Day, Caroline, Russell, Peter, Boyer, Cinda M., Kerns, Billie‐Jo M., Wiener, Jon R., Jensen, Debra N., Bast, Robert C., Hacker, Neville F.

“…BACKGROUND Tumors of borderline malignancy are still a controversial subgroup of ovarian neoplasms. The expression of several cell regulatory proteins was…”
Get full text

Relation between p53 overexpression and established prognostic factors in breast cancer by Davidoff, A M, Herndon, 2nd, J E, Glover, N S, Kerns, B J, Pence, J C, Iglehart, J D, Marks, J R

“…The nuclear phosphoprotein p53 is expressed in all normal cells and appears to function in cell cycle regulation. Abnormally high levels of the protein are…”
Get more information

Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis. Commentary by LAYFIELD, L. J, SARIA, E. A, BERCHUCK, A, DODGE, R. K, THOMPSON, J. K, CONLON, D. H, KERNS, B.-J. M, MEYER, J. S

Get full text

Histochemical staining of protein-tyrosine phsophatase activity in primary human mammary carcinoma : realtionship with established prognostic indicators by KIDD, K. R, KERNS, B. J. M, DODGE, R. K, WIENER, J. R

Get full text

p53 alterations in all stages of breast cancer by Davidoff, A M, Kerns, B J, Pence, J C, Marks, J R, Iglehart, J D

“…Overexpression of the nuclear phosphoprotein p53 is one of the most frequently detected abnormalities in human cancer and appears to be associated with…”
Get more information

Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression by Wiener, J R, Kerns, B J, Harvey, E L, Conaway, M R, Iglehart, J D, Berchuck, A, Bast, Jr, R C

“…The p185c-erbB-2 growth factor receptor protein tyrosine kinase (PTK) is overexpressed in one third of human breast cancer patients and indicates a poor…”
Get more information

Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining by Pence, J C, Kizilbash, A M, Kerns, B J, Marks, J R, Iglehart, J D

“…To investigate factors involved in progression of breast cancer, we estimated the growth fraction of malignant cell populations in various stages of mammary…”
Get more information